Glooko

Executive Summary

Glooko is a leading digital health platform focused on transforming diabetes care by aggregating and analyzing data from patients, providers, and devices. Founded in 2010 and headquartered in Palo Alto, Glooko simplifies diabetes data management, enhances clinical workflows, and drives measurable health outcomes. With the global diabetes epidemic accelerating demand for remote monitoring and integrated care solutions, Glooko is well-positioned to capture market share. Its platform connects over 200 glucose meters, insulin pumps, and continuous glucose monitors (CGMs), providing a unified view for healthcare professionals and patients. The company’s value proposition centers on reducing the burden of diabetes management while improving clinical decision-making through actionable insights. As a mature private company, Glooko has secured significant funding and expanded its commercial footprint across multiple countries.

Upcoming Catalysts (preview)

• Q2 2026Launch of AI-driven predictive analytics for glucose management80% success
• H2 2026Major partnership with a top-10 U.S. health system for population health management60% success
• Q3 2026FDA clearance for expanded CGM integration or new feature75% success